{"database": "lobbying", "table": "lobbying_activities", "rows": [[1115392, "4b7319f5-0af1-447a-95a3-108d17f095a2", "Q2", "W STRATEGIES, LLC", 400605842, "23ANDME, INC.", 2011, "second_quarter", "MED", "Issues relating to FDA regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine.", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2011-07-17T13:28:04.440000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1115392"], "units": {}, "query_ms": 5.326664075255394, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}